TWD 46.65
(0.43%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 132.78 Million TWD | 10.19% |
2022 | 120.89 Million TWD | 7.58% |
2021 | 112.37 Million TWD | 8.12% |
2020 | 103.93 Million TWD | 3.0% |
2019 | 100.91 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 31.39 Million TWD | -8.18% |
2024 Q2 | 29.67 Million TWD | -0.4% |
2023 Q2 | 34.31 Million TWD | 12.3% |
2023 Q4 | 34.19 Million TWD | 0.13% |
2023 FY | 133.21 Million TWD | 10.19% |
2023 Q1 | 30.55 Million TWD | 0.92% |
2023 Q3 | 34.14 Million TWD | -0.5% |
2022 Q3 | 28.27 Million TWD | 0.0% |
2022 FY | 120.89 Million TWD | 7.58% |
2022 Q4 | 30.27 Million TWD | 7.11% |
2021 FY | 112.37 Million TWD | 8.12% |
2020 FY | 103.93 Million TWD | 3.0% |
2019 FY | 100.91 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Allied Biotech Corporation | 157.72 Million TWD | 15.812% |
Easywell Biomedicals, Inc. | 333.45 Million TWD | 60.179% |
TTY Biopharm Company Limited | 1.91 Billion TWD | 93.054% |
Synmosa Biopharma Corporation | 1.49 Billion TWD | 91.145% |
Orient EuroPharma Co., Ltd. | 2.14 Billion TWD | 93.816% |
Center Laboratories, Inc. | 697.35 Million TWD | 80.959% |
Tien Liang BioTech Co., Ltd. | 267.27 Million TWD | 50.318% |
Orient Pharma Co., Ltd. | 468.66 Million TWD | 71.667% |
InnoPharmax Inc. | 82.29 Million TWD | -61.352% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 244.63 Million TWD | 45.72% |
Excelsior Biopharma Inc. | 388.05 Million TWD | 65.782% |
DV Biomed Co., Ltd. | 575.24 Million TWD | 76.917% |
Foresee Pharmaceuticals Co., Ltd. | 1.12 Billion TWD | 88.161% |
Handa Pharmaceuticals, Inc. | 399.14 Million TWD | 66.733% |
UniPharma Co., Ltd. | 78.32 Million TWD | -69.541% |
Anxo Pharmaceutical Co., Ltd. | 396.93 Million TWD | 66.547% |
Alar Pharmaceuticals Inc. | 83.74 Million TWD | -58.56% |
Winston Medical Supply Co., Ltd. | 151.49 Million TWD | 12.351% |
Mercury Biopharmaceutical Corporation | 592 Thousand TWD | -22330.068% |
Bioray Biotech Co., Ltd | 96.98 Million TWD | -36.918% |
TSH Biopharm Corporation Limited | 336.26 Million TWD | 60.512% |